CTNM
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ: CTNM · HEALTHCARE · BIOTECHNOLOGY
$12.82
+6.48% today
Updated 2026-04-30
Market cap
$463.34M
P/E ratio
—
P/S ratio
11.15x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$3 – $16
Volume
0.3M
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |